세계의 진단용 심전계 시장 규모 조사 및 예측 : 제품 및 서비스별, 리드 유형별, 최종 사용자별, 지역별 분석(2023-2030년)

Global Diagnostic Electrocardiograph (ECG) Market is valued at approximately USD 7.58 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.9% during the forecast period 2023-2030. A Diagnostic Electrocardiograph (ECG) is a medical device that records the heart's electrical activity. It helps diagnose heart conditions by measuring electrical signals as the heart beats. The ECG provides valuable information about heart rhythm, rate, and abnormalities, aiding doctors in making treatment decisions. The global market is witnessing growth primarily due to the escalating of the elderly population worldwide, leading to an increased incidence of heart-related conditions. The United Nations' World Population Ageing Report of 2019 indicated that there were 703 million individuals aged 65 or older worldwide in 2019, with projections indicating that this figure is expected to double, reaching 1.5 billion by 2050. Additionally, the rise in research funding and grants dedicated to the cardiac diagnosis, along with supportive government initiatives, is primarily attributed to the market growth across the globe.

Additionally, the rise in the incidence of lifestyle and cardiovascular diseases is also directly associated with the need for various diagnostic and treatment alternatives, which, in turn, accelerates the market growth at a substantial rate. These devices are used in early detection, screening programs, and monitoring of chronic conditions associated with heart health. The World Health Organization (WHO) stated that cardiovascular diseases (CVDs) are the major reason of mortality worldwide, accounted for around 17.9 million lives per year. Moreover, technological advancements have led to the development of portable and wearable ECG devices, enhancing patient compliance, and enabling real-time monitoring. With the aging population, there is a growing need for non-invasive cardiac assessment tools, making ECGs essential for diagnosing and managing heart conditions in elderly patients. Thus, the increasing prevalence of cardiovascular diseases highlights the crucial importance of Diagnostic Electrocardiographs in enhancing cardiac care and intervention approaches, which is propelling the growth of the Diagnostic Electrocardiograph (ECG) Market over the estimated period. Furthermore, the development of wireless monitoring and wearable cardiac devices, as well as the rising integration of ECGs into telemedicine platforms and remote monitoring solutions present various lucrative opportunities over the forecast years. However, the stringent regulatory requirements delaying the approval of cardiac devices and the dearth of skilled professionals are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Diagnostic Electrocardiograph (ECG) Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising prevalence of cardiovascular disease, robust healthcare infrastructure, expanding aging population, and increased adoption of remote monitoring devices. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rapid rise in population, increasing disposable income, and the development of healthcare infrastructure are significantly propelling the market demand across the region.

Major market players included in this report are:

• GE HealthCare (US)
• Koninklijke Philips N.V. (Netherlands)
• Nihon Kohden Corporation (Japan)
• OSI Systems, Inc. (US)
• Hill-Rom Holdings, Inc. (Baxter International Inc.) (US)
• ACS Diagnostics Inc. (US)
• Fukuda Denshi Co. Ltd. (Japan)
• BioTelemetry, Inc. (US)
• OSI Systems, Inc. (US)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

Recent Developments in the Market:

• In April 2022, GE Healthcare entered a partnership with Deep Cardio to co-create AI-based ECG diagnostic technology and an ECG data analysis program.
• In February 2021, Royal Philipscompleted the acquisition of BioTelemetry, Inc., and Capsule Technologies, both based in the US. This strategic move aimed to enhance Philips' cardiac care portfolio, including cardiac diagnostics and monitoring services, within its Connected Care segment.

Global Diagnostic Electrocardiograph (ECG) Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product and Service, Lead Type, End User, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product and Service:

• Resting ECG
• Stress ECG Devices
• Holter Monitors
• Implantable Loop Recorders
• Event Monitors
• MCT Devices
• Smart ECG Monitors

By Lead Type:

• 12-lead
• 5-lead
• 3-lead
• 6-lead
• Single lead
• Other lead types

By End User:

• Hospitals
• Clinics and Cardiac Centers
• Ambulatory Surgical Centers
• Other End Users

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Diagnostic Electrocardiograph (ECG) Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Diagnostic Electrocardiograph (ECG) Market, by Product and Service, 2020-2030 (USD Billion)
  • 1.2.3.Diagnostic Electrocardiograph (ECG) Market, by Lead Type, 2020-2030 (USD Billion)
  • 1.2.4.Diagnostic Electrocardiograph (ECG) Market, by End User, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Diagnostic Electrocardiograph (ECG) Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Diagnostic Electrocardiograph (ECG) Market Dynamics

• 3.1.Diagnostic Electrocardiograph (ECG) Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing research funding and grants dedicated to cardiac diagnosis
    • 3.1.1.2.Rising incidence of lifestyle and cardiovascular diseases
  • 3.1.2.Market Challenges
    • 3.1.2.1.Stringent regulatory requirements delaying approval of cardiac devices
    • 3.1.2.2.Dearth of skilled professionals
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Development of wireless monitoring and wearable cardiac devices
    • 3.1.3.2.Rising integration of ECGs into telemedicine platforms and remote monitoring solutions

Chapter 4.Global Diagnostic Electrocardiograph (ECG) Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Diagnostic Electrocardiograph (ECG) Market, by Product and Service

• 5.1.Market Snapshot
• 5.2.Global Diagnostic Electrocardiograph (ECG) Market by Product and Service, Performance - Potential Analysis
• 5.3.Global Diagnostic Electrocardiograph (ECG) Market Estimates & Forecasts by Product and Service 2020-2030 (USD Billion)
• 5.4.Diagnostic Electrocardiograph (ECG) Market, Sub Segment Analysis
  • 5.4.1.Resting ECG
  • 5.4.2.Stress ECG Devices
  • 5.4.3.Holter Monitors
  • 5.4.4.Implantable Loop Recorders
  • 5.4.5.Event Monitors
  • 5.4.6.MCT Devices
  • 5.4.7.Smart ECG Monitors

Chapter 6.Global Diagnostic Electrocardiograph (ECG) Market, by Lead Type

• 6.1.Market Snapshot
• 6.2.Global Diagnostic Electrocardiograph (ECG) Market by Lead Type, Performance - Potential Analysis
• 6.3.Global Diagnostic Electrocardiograph (ECG) Market Estimates & Forecasts by Lead Type 2020-2030 (USD Billion)
• 6.4.Diagnostic Electrocardiograph (ECG) Market, Sub Segment Analysis
  • 6.4.1. 12-lead
  • 6.4.2. 5-lead
  • 6.4.3. 3-lead
  • 6.4.4. 6-lead
  • 6.4.5. Single lead
  • 6.4.6. Other lead types

Chapter 7.Global Diagnostic Electrocardiograph (ECG) Market, by End User

• 7.1.Market Snapshot
• 7.2.Global Diagnostic Electrocardiograph (ECG) Market by End User, Performance - Potential Analysis
• 7.3.Global Diagnostic Electrocardiograph (ECG) Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 7.4.Diagnostic Electrocardiograph (ECG) Market, Sub Segment Analysis
  • 7.4.1.Hospitals
  • 7.4.2.Clinics and Cardiac Centers
  • 7.4.3.Ambulatory Surgical Centers
  • 7.4.4.Other End Users

Chapter 8.Global Diagnostic Electrocardiograph (ECG) Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Diagnostic Electrocardiograph (ECG) Market, Regional Market Snapshot
• 8.4.North America Diagnostic Electrocardiograph (ECG) Market
  • 8.4.1.U.S. Diagnostic Electrocardiograph (ECG) Market
    • 8.4.1.1.Product and Service breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Lead Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Diagnostic Electrocardiograph (ECG) Market
• 8.5.Europe Diagnostic Electrocardiograph (ECG) Market Snapshot
  • 8.5.1.U.K. Diagnostic Electrocardiograph (ECG) Market
  • 8.5.2.Germany Diagnostic Electrocardiograph (ECG) Market
  • 8.5.3.France Diagnostic Electrocardiograph (ECG) Market
  • 8.5.4.Spain Diagnostic Electrocardiograph (ECG) Market
  • 8.5.5.Italy Diagnostic Electrocardiograph (ECG) Market
  • 8.5.6.Rest of Europe Diagnostic Electrocardiograph (ECG) Market
• 8.6.Asia-Pacific Diagnostic Electrocardiograph (ECG) Market Snapshot
  • 8.6.1.China Diagnostic Electrocardiograph (ECG) Market
  • 8.6.2.India Diagnostic Electrocardiograph (ECG) Market
  • 8.6.3.Japan Diagnostic Electrocardiograph (ECG) Market
  • 8.6.4.Australia Diagnostic Electrocardiograph (ECG) Market
  • 8.6.5.South Korea Diagnostic Electrocardiograph (ECG) Market
  • 8.6.6.Rest of Asia Pacific Diagnostic Electrocardiograph (ECG) Market
• 8.7.Latin America Diagnostic Electrocardiograph (ECG) Market Snapshot
  • 8.7.1.Brazil Diagnostic Electrocardiograph (ECG) Market
  • 8.7.2.Mexico Diagnostic Electrocardiograph (ECG) Market
• 8.8.Middle East & Africa Diagnostic Electrocardiograph (ECG) Market
  • 8.8.1.Saudi Arabia Diagnostic Electrocardiograph (ECG) Market
  • 8.8.2.South Africa Diagnostic Electrocardiograph (ECG) Market
  • 8.8.3.Rest of Middle East & Africa Diagnostic Electrocardiograph (ECG) Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.GE HealthCare (US)
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Koninklijke Philips N.V. (Netherlands)
  • 9.3.3.Nihon Kohden Corporation (Japan)
  • 9.3.4.OSI Systems, Inc. (US)
  • 9.3.5.Hill-Rom Holdings, Inc. (Baxter International Inc.) (US)
  • 9.3.6.ACS Diagnostics. (US)
  • 9.3.7.Fukuda Denshi Co. Ltd. (Japan)
  • 9.3.8.BioTelemetry, Inc. (US)
  • 9.3.9.OSI Systems, Inc. (US)
  • 9.3.10.Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption